- E03.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E03.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E03.1 – other international versions of ICD-10 E03.1 may differ.
ICD-10-CM E03.1 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Aplasia of thyroid (with myxedema)
- Congenital atrophy of thyroid
- Congenital hypothyroidism NOS
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E03.1:
- congenital > thyroid (gland) (acquired) E89.0
- thyroid (gland) > Agenesis
- thyroid (congenital) (with myxedema) > Aplasia
- congenital > Athyrea (acquired)
- with cretinism > thyroid (gland) (acquired) E03.4
- congenital (with myxedema) > thyroid (gland) (acquired) E03.4
- thyroid (gland) > Hypoplasia, hypoplastic
- congenital (without goiter) > Hypothyroidism (acquired) E03.9
- congenital > thyroid (gland) (acquired) E03.9
- hypothyroidism, congenital > due to or associated with
- congenital > Subthyroidism (acquired)